The Discounted Cash Flow (DCF) valuation of 10X Genomics Inc (TXG) is (66.20) USD. With the latest stock price at 9.39 USD, the upside of 10X Genomics Inc based on DCF is -805.0%.
Based on the latest price of 9.39 USD and our DCF valuation, 10X Genomics Inc (TXG) is a sell. selling TXG stocks now will result in a potential gain of 805.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 7.6% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (148.99) - (42.92) | (66.20) |
| Upside | -1686.7% - -557.0% | -805.0% |